Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
I'm Alethia Young. I am one of the analysts here, covering biotech at Cantor. I am also Head of Healthcare Research. We're happy to have Alnylam, who I cover. We're going to do a fireside chat, of course, with Yvonne Greenstreet, COO; and Jeff Poulton, CFO.
Questions & Answers
And so we'll just kind of dive right out into it. I don't think we need an introduction here. I'll talk about some of the things, questions I get from investors on a pretty consistent basis about you guys, whether it's in the United States or in Europe. And we'll just kind of work through those issues.
So obviously, like, everybody is very focused on ONPATTRO launch. So I just wanted you guys to kind of characterize its background for what you've seen so far in sales; and then just how you're thinking about the kind of the next couple of quarters; and how that near-term progress
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
